loading
전일 마감가:
$24.58
열려 있는:
$24.61
하루 거래량:
2.08M
Relative Volume:
1.67
시가총액:
$3.04B
수익:
$460.48M
순이익/손실:
$142.80M
주가수익비율:
21.15
EPS:
1.18
순현금흐름:
$221.79M
1주 성능:
+1.92%
1개월 성능:
+2.80%
6개월 성능:
+13.09%
1년 성능:
+54.93%
1일 변동 폭
Value
$24.18
$25.23
1주일 범위
Value
$24.18
$25.23
52주 변동 폭
Value
$14.75
$26.16

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Name
명칭
Catalyst Pharmaceuticals Inc
Name
전화
(305) 529-2522
Name
주소
355 ALHAMBRA CIRCLE, CORAL GABLES
Name
직원
167
Name
트위터
@CatalystForRare
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
CPRX's Discussions on Twitter

CPRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CPRX
Catalyst Pharmaceuticals Inc
24.96 2.99B 460.48M 142.80M 221.79M 1.18
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-04 개시 Robert W. Baird Outperform
2024-11-18 개시 Stephens Overweight
2024-03-14 개시 Citigroup Buy
2024-03-07 개시 BofA Securities Buy
2023-12-21 개시 Oppenheimer Outperform
2022-08-24 다운그레이드 ROTH Capital Buy → Neutral
2018-09-21 개시 Cantor Fitzgerald Overweight
2018-09-07 재개 Piper Jaffray Overweight
2016-10-05 업그레이드 Piper Jaffray Neutral → Overweight
2016-04-26 다운그레이드 Piper Jaffray Overweight → Neutral
2014-09-30 재확인 ROTH Capital Buy
2014-09-16 재확인 ROTH Capital Buy
2014-09-15 재확인 H.C. Wainwright Buy
2013-10-21 재확인 Aegis Capital Buy
2013-09-24 개시 Maxim Group Buy
2013-09-06 재확인 Aegis Capital Buy
2013-04-18 개시 Aegis Capital Buy
2012-08-27 업그레이드 Rodman & Renshaw Mkt Perform → Mkt Outperform
2009-10-01 업그레이드 Merriman Sell → Neutral
2009-05-29 다운그레이드 Hapoalim Neutral → Underperform
2009-05-29 다운그레이드 Merriman Curhan Ford Buy → Sell
2008-12-15 개시 Merriman Curhan Ford Buy
2007-11-28 개시 Rodman & Renshaw Mkt Outperform
2007-01-31 개시 Stifel Nicolaus Buy
2007-01-05 개시 First Albany Buy
모두보기

Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스

pulisher
03:16 AM

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

03:16 AM
pulisher
01:19 AM

Zacks Research Brokers Raise Earnings Estimates for CPRX - Defense World

01:19 AM
pulisher
May 30, 2025

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Earnings Are Not Doing Enough For Some Investors - simplywall.st

May 30, 2025
pulisher
May 27, 2025

ProShare Advisors LLC Boosts Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

May 27, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Buys Shares of 18,173 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

May 27, 2025
pulisher
May 25, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Position Decreased by Jane Street Group LLC - Defense World

May 25, 2025
pulisher
May 24, 2025

Cetera Investment Advisers Grows Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

May 24, 2025
pulisher
May 24, 2025

Ameriprise Financial Inc. Grows Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

May 24, 2025
pulisher
May 20, 2025

Transcript : Catalyst Pharmaceuticals, Inc.Shareholder/Analyst Call - marketscreener.com

May 20, 2025
pulisher
May 14, 2025

Catalyst Pharmaceuticals at Bank of America 2025: Strategic Expansion and Growth - Investing.com Canada

May 14, 2025
pulisher
May 14, 2025

Transcript : Catalyst Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business - Yahoo Finance

May 14, 2025
pulisher
May 11, 2025

Catalyst pharmaceuticals reaffirms 2025 revenue guidance of $545M-$565M with strong FIRDAPSE and AGAMREE performance - MSN

May 11, 2025
pulisher
May 11, 2025

(CPRX) Trading Signals - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - MSN

May 11, 2025
pulisher
May 09, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Catalyst Pharmaceuticals Reports Record Q1 2025 Results - TipRanks

May 09, 2025
pulisher
May 09, 2025

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo

May 09, 2025
pulisher
May 09, 2025

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $32.29 Consensus PT from Analysts - Defense World

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: Catalyst Pharmaceuticals Q1 2025 earnings beat fails to impress market - Investing.com UK

May 08, 2025
pulisher
May 08, 2025

Catalyst Pharmaceuticals Reports Robust Growth in Earnings Call - TipRanks

May 08, 2025
pulisher
May 07, 2025

Catalyst Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Catalyst Pharmaceuticals (CPRX) Exceeds Q1 Revenue Expectations - GuruFocus

May 07, 2025
pulisher
May 07, 2025

CPRX Reaffirms Positive 2025 Revenue Outlook | CPRX Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Catalyst Pharma Reports Record Q1 2025 Financial Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

Earnings Flash (CPRX) Catalyst Pharmaceuticals Reports Q1 Revenue $141.4M, vs. FactSet Est of $131.5M - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Earnings Flash (CPRX) Catalyst Pharmaceuticals Reports Q1 Adjusted EPS $0.68, vs. FactSet Est of $0.48 - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus

May 07, 2025
pulisher
May 03, 2025

BlackRock, Inc. Reduces Stake in Catalyst Pharmaceuticals Inc - GuruFocus

May 03, 2025
pulisher
Apr 30, 2025

How To Trade (CPRX) - news.stocktradersdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Catalyst Pharmaceuticals to Participate in the BofA Securities H - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025 - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist? - Yahoo

Apr 30, 2025
pulisher
Apr 30, 2025

Catalyst Pharmaceuticals Leadership Team to Share Rare Disease Strategy at Major BofA Healthcare Conference - Stock Titan

Apr 30, 2025
pulisher
Apr 28, 2025

Catalyst Pharmaceuticals (NASDAQ:CPRX) stock performs better than its underlying earnings growth over last five years - simplywall.st

Apr 28, 2025
pulisher
Apr 27, 2025

Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now - MSN

Apr 27, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Catalyst Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch

Apr 25, 2025
pulisher
Apr 22, 2025

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025 | CPRX Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Catalyst Pharmaceuticals to Release First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - Nasdaq

Apr 22, 2025
pulisher
Apr 22, 2025

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025 - GlobeNewswire

Apr 22, 2025
pulisher
Apr 21, 2025

BofA Adjusts Price Target on Catalyst Pharmaceuticals to $34 From $33 - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Catalyst Pharmaceuticals (CPRX) Sees Price Target Boost from Bof - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Catalyst Pharmaceuticals (CPRX) Sees Price Target Boost from BofA to $34 | CPRX Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 19, 2025

LPL Financial LLC Buys 15,961 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2025
pulisher
Apr 15, 2025

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 15, 2025
pulisher
Apr 15, 2025

(CPRX) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 15, 2025

Catalyst Pharmaceuticals Inc (CPRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):